Please login to the form below
sales
This page shows the latest sales news and features for those working in and with pharma, biotech and healthcare.
Roche’s Hemlibra scores broader NHS funding
penetration. . The drug is proving to be a star performer for Roche globally, achieving sales of $538m in the first half of 2019, and is taking market share from a host
Latest news
-
NICE’s fast-track catapults Skyrizi into market
SVB Leerink analyst Geoffrey Porges predicts $3bn in peak sales for AbbVie's Skyrizi, with its success dependent on how it will fare not just in psoriasis but the other
-
GSK files anaemia drug daprodustat in Japan, its first market
drugs could eventually generate several billions of dollars in sales.
-
AZ’s Imfinzi combo bombs again in non-small cell lung cancer
The PD-L1 inhibitor was approved for this use on the back of the PACIFIC trial, and it is behind an acceleration in Imfinzi sales which rose 244% to $633m in
-
FDA rejects Sarepta’s new Duchenne drug over safety fears
Analysts at Leerink estimate the three drugs could reach sales of $1.7bn by 2024, a figure boosted by the fact that the company is currently well ahead of potential rivals
-
Lilly’s Levi Garraway will replace Sandra Horning as Roche CMO
its ‘big three’ antibiotic products – Rituxan, Herceptin and Avastin – which accounted for more than a third of sales last year.
More from news
Approximately 37 fully matching, plus 5,202 partially matching documents found.
Latest Intelligence
-
Re-imagining content supply chains for a next-gen customer experience in pharma
by Marc Valdiviezo
-
The trials and tribulations of rare opportunities
Revenue projection in the year 2025 is $1.259bn,” he continued. Ringheim cited Celgene’s beta thalassemia candidate Sotatercept, which is expected to achieve sales of $458m by 2023, as a
-
Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019
Forecast sales for Skyrizi in 2023 are $1.74bn. AR-101 from Aimmune Therapeutics addresses peanut allergy. ... It is currently in phase 3 in the US. The sales forecast for 2023 are $1.12bn.
-
The UK’s new medicines pricing deal – opportunities and risks for pharma
There are differences this time around, with the calculations including sales in the VPAS, the statutory scheme, and parallel imports. ... if forecast sales of new active substances are expected to go over £20m.
-
Gene therapy market access Q&A
Jesper Jorgensen, Health Economics and Market Access Manager, Cell and Gene Therapy Catapult gives his personal view on how to get the new therapies to patients
More from intelligence
Approximately 21 fully matching, plus 527 partially matching documents found.
Latest appointments
-
New hires at Ferring, Flexion and Immunocore
The latest movers in pharma
-
New hires at Nanoform, Leo Pharma and Calliditas
The latest movers in pharma and biotech
-
Changes at Oxford PharmaGenesis, Reynolds-Mackenzie and more
He has 30 years’ experience in sales and marketing within the pharmaceutical industry having previously held roles for AstraZeneca and ALK.
-
Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership team
The latest industry movers
-
Ashfield, Health Unlimited and Ashley Communications add to their teams
The latest med comms movers. Ashfield appoints Novo’s sales and marketing director. ... He brings to us a rare blend of pharmaceutical sales and marketing expertise as well as services sector understanding.
More from appointments
Approximately 0 fully matching, plus 817 partially matching documents found.
Latest from PMHub
-
Blended Intelligence
This empathetic approach has provided a halo effect for Fresenius Kabi’s reputation, as well as inspiring the sales team to launch this campaign with enthusiasm. ... Generate greater internal support from the sales team. Entice influencers to support
-
Planning a pharma exhibition stand? You must read this!
For example, raising brand awareness, networking, showcasing a new product, or sales.
-
Eoin McAtamney announced as Managing Director of Ashfield Ireland
Eoin joins Ashfield from Fresenius Kabi in Ireland where he was National Sales Manager. ... Previously Eoin has gained sales experience in both the pharma and CSO environments.
-
See why so many clients choose the Ashfield contact centre in our new video
Contact centres are an increasingly popular way for pharmaceutical and healthcare companies to target customers in a more holistic way than field medical sales reps alone.
-
Tools to action your segmentation
Our tools for ensuring a successful segmentation rollout. For a truly successful segmentation, it is critical that the marketing and sales teams are engaged at key points in the process, and
More from PMHub
Approximately 45 fully matching, plus 574 partially matching documents found.
Featured jobs
- Account Director, Healthcare Communications
-
Salary TBC
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
-
Account Director – UK Office
-
Excellent salary and benefits
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
Subscribe to our email news alerts
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Moving annual total (MAT)
- GSK hires Merck KGaA exec to lead US pharma business
- Roche undercuts price of Bayer cancer drug after winning FDA approval
- Leaked no-deal Brexit document forecasts widespread shortages
- Novartis chooses internal replacement for US pharma president role
PMHub
Valid Insight
Valid Insight is an award-winning pharmaceutical global market access consultancy....
Latest intelligence
- Empowered patients: shaking the foundations of healthcare
- Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
- A uniquely English genomic medicine service
- The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
Quick links
Infographics
